About Boehringer Ingelheim:
Boehringer Ingelheim is a research-driven pharmaceutical company and one of the top 20 pharmaceutical firms worldwide. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally in over 100 countries and has more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2016, Boehringer Ingelheim achieved net sales of about 15.8 billion euros. R&D expenditure corresponds to 23.1% of its net sales.